BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9018801)

  • 1. IgG anti-D MAbs in tests by flow cytometry.
    Roubinet F; Blancher A
    Transfus Clin Biol; 1996; 3(6):419-23. PubMed ID: 9018801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometric evaluation of non anti-RH1(D) monoclonal Rh antibodies.
    Le Pennec PY; Gane P; Noizat-Pirenne F; Braddock D; Cartron JP; Rouger P
    Transfus Clin Biol; 1996; 3(6):433-5. PubMed ID: 9018804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies directed against human Rh antigens in tests with red cells of non-human primates.
    Blancher A; Socha WW; Roubinet F; Ruffié J
    Transfus Clin Biol; 1996; 3(6):339-45. PubMed ID: 9018786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometric analysis of 68 monoclonal anti-D reagents.
    Lubenko A; Johnson A
    Transfus Clin Biol; 1996; 3(6):415-7. PubMed ID: 9018800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional activity of human Rh monoclonal antibodies (MABS).
    Kumpel BM
    J Immunogenet; 1990; 17(4-5):321-30. PubMed ID: 2128776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Partial deletion of the D antigen in a family group. Determination of its antigenic density by flow cytometry].
    Hernández T; León G; Sánchez P
    Sangre (Barc); 1994 Apr; 39(2):139-43. PubMed ID: 7520193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of IgG anti-D bound to D-positive red cells infused into D-negative subjects after intramuscular injection of monoclonal anti-D.
    Kumpel BM; Judson PA
    Transfus Med; 1995 Jun; 5(2):105-12. PubMed ID: 7655572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human monoclonal anti-D antibodies. I. Their production, serology, quantitation and potential use as blood grouping reagents.
    Kumpel BM; Poole GD; Bradley BA
    Br J Haematol; 1989 Jan; 71(1):125-9. PubMed ID: 2492817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of LOR-15C9 monoclonal anti-D to differentiate erythrocytes with the partial DvI antigen from those with either partial D antigens or weak D antigens.
    Reid ME; Halverson GR; Roubinet F; Apoil PA; Blancher A
    Immunohematology; 1998; 14(3):89-93. PubMed ID: 15377187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency of partial D phenotypes in the south western region of France.
    Roubinet F; Apoil PA; Blancher A
    Transfus Clin Biol; 1996; 3(4):247-55. PubMed ID: 8933677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactivity of 62 Rh MAbs with weak and variant antigens.
    Morelati F; Revelli N; Drago F; Mancuso P; Sirchia G
    Transfus Clin Biol; 1996; 3(6):359-66. PubMed ID: 9018789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specificity C and e: tests using Rh variant cells.
    Smart EA; Reddy V
    Transfus Clin Biol; 1996; 3(6):355-7. PubMed ID: 9018788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactivity of FDA-approved anti-D reagents with partial D red blood cells.
    Judd WJ; Moulds M; Schlanser G
    Immunohematology; 2005; 21(4):146-8. PubMed ID: 16472014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phagocytosis by human monocytes of red cells sensitized with monoclonal IgG1 and IgG3 anti-D.
    Hadley AG; Kumpel BM
    Vox Sang; 1989; 57(2):150-1. PubMed ID: 2506695
    [No Abstract]   [Full Text] [Related]  

  • 15. ISBT monoclonal antibody workshop: report on group 3 (anti-Rh) antibodies.
    Lubenko A; Burslem SJ; Tandy J; Contreras M; Garner SF; Wiener E
    Rev Fr Transfus Immunohematol; 1988 Apr; 31(2):145-52. PubMed ID: 3145543
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of DATs using traditional tube agglutination to gel column and affinity column procedures.
    Dittmar K; Procter JL; Cipolone K; Njoroge JM; Miller J; Stroncek DF
    Transfusion; 2001 Oct; 41(10):1258-62. PubMed ID: 11606825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serological studies of monoclonal RH antibodies with RH1 (D), RH2 (C), RH3 (E) and RH5 (e) variant RBCs.
    Noizat-Pirenne F; Ansart-Pirenne H; Ménanteau C; Braddock D; Rouzaud AM; Klein MT; Patereau C; Rouger P; Le Pennec PY
    Transfus Clin Biol; 2003 Oct; 10(5):319-23. PubMed ID: 14572547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Labeling D+ RBCs for flow cytometric quantification of fetomaternal hemorrhage after the RBCs have been coated with anti-D.
    Kumpel BM
    Transfusion; 2001 Aug; 41(8):1059-63. PubMed ID: 11493739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Section 1B: Rh flow cytometry. Coordinator's report. Rhesus index and antigen density: an analysis of the reproducibility of flow cytometric determination.
    Flegel WA; Curin-Serbec V; Delamaire M; Donvito B; Ikeda H; Jørgensen J; Kumpel B; Le Pennec PY; Písacka M; Tani Y; Uchikawa M; Wendel S; Wagner FF
    Transfus Clin Biol; 2002 Jan; 9(1):33-42. PubMed ID: 11889898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative blood group typing using surface plasmon resonance.
    Then WL; Aguilar MI; Garnier G
    Biosens Bioelectron; 2015 Nov; 73():79-84. PubMed ID: 26047997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.